by healthadvances Posted on February 27, 2020April 13, 2020 Reflecting on the 17th Annual HBS Healthcare Conference Read More
by healthadvances Posted on January 14, 2020April 13, 2020 Bridging the Gap in Clinical and Economic Evidence for Digital Health Tech in the UK Read More
by healthadvances Posted on July 23, 2019December 7, 2021 E-Health in Germany: Three New Laws Signify the Imminent Transformation to a Digitalised Healthcare System Read More
by healthadvances Posted on April 11, 2019April 13, 2020 The Opportunity for Real-World Data and Evidence in Ophthalmology Read More
by healthadvances Posted on December 10, 2018April 13, 2020 Amazon’s Healthcare Strategy Hinges on Data Read More
by healthadvances Posted on October 2, 2018April 13, 2020 E-Health in Germany: Rapid Progression of Digitalisation? Read More
by healthadvances Posted on August 23, 2018April 13, 2020 Disease Management Programs (DMPs) in Germany: The Importance of Guideline Inclusion for Chronic Therapies Read More
by healthadvances Posted on August 1, 2018April 13, 2020 Putting Cerner’s Big Investment in Lumeris Into Strategic Context Read More
by healthadvances Posted on May 11, 2018April 15, 2020 Scaling the Mountain: Adoption Strategy for Digital Health Read More
by healthadvances Posted on April 4, 2018April 15, 2020 Three Models for Population Health Technology Read More
by healthadvances Posted on March 14, 2018April 15, 2020 Seattle’s Journey to the Summit of Cancer Commercialization Read More
by healthadvances Posted on March 13, 2018April 15, 2020 The Accelerated Access Review in the UK: Quicker Access to Innovative Drugs and Diagnostics, Medical and Digital Technologies Read More
by healthadvances Posted on February 16, 2018April 15, 2020 Why Flatiron’s Big Exit May Not Be the Boon for Digital Health That Some Expect Read More
by healthadvances Posted on January 19, 2018April 15, 2020 PART 3: What’s Next in 2018? Advanced Therapeutics – Gene Therapy, CAR-T, and Microbiome Read More
by healthadvances Posted on January 16, 2018April 15, 2020 PART 2: 2018 Wildcards – Healthcare Regulation and Models of Care Read More
by healthadvances Posted on November 13, 2017April 15, 2020 Who’s Really First in FDA Cleared Digital Therapeutics? Read More
by healthadvances Posted on August 10, 2016April 15, 2020 New Digital Health Solutions are Hot; but Success is Still Grounded in Fundamental Rules of Commercialization Read More
by healthadvances Posted on June 6, 2016April 15, 2020 Envisioning the Future of Digital Health Read More
by healthadvances Posted on October 15, 2015April 15, 2020 Market Forces Begin to Cut Through the Hype on Mobile Health Tech Read More
by healthadvances Posted on July 22, 2015April 15, 2020 How Much Longer Before Biopharma Embraces Remote Monitoring in Clinical Trials? Read More
